Abstract:Inflammation is critical in progression of hypertension. However, how an elevated blood pressure (BP) initiates inflammation is unknown, as are the precise effects of high BP on the immune responses. To study this, we first challenged mice with antigen ovalbumin (OVA). Two-fold more OVA-specific CD8 + T cells were present in the blood (2.7 ± 0.23% vs. 1.2 ± 0.47%) and spleen (2.62 ± 0.31% vs. 1.31 ± 0.17%) of angiotensin (Ang) II induced hypertensive mice as compared to those of normotensive controls. To address whether the over-activation of T cell-mediated immune responses is pathogenic, two models of autoimmune disease were studied. RIP-mOVA is a transgenic mouse line that expresses OVA in pancreatic islet β cells. When OVA-specific OT-I T cells were infused into Rip-mOVA mice, the animals with hypertension induced by either Ang II or L-NAME developed more severe diabetes (blood glucose (mg/dl): Ang II 331, L-NAME 315 vs. Control 168). Concanavalin A-induced hepatitis was also significantly worsened by hypertension as compared to the pathology observed in normotensive mice. After examining the characteristics of T cells and antigen presenting cells (APCs), we found that the most distinguishable difference in hypertensive mice was the upregulation of CD86 on APCs. Blocking CD86 by antibody completely abrogated the elevated immune responses in hypertensive mice. To understand what causes CD86 upregulation in APCs of hypertensive mice, we studied damage-associated molecular patterns and found that plasma ATP levels rose as early as 3 days after the induction of hypertension and reached from about 1μM of baseline to a peak level of 3 μM after 2 weeks of hypertension, which exactly parallels the kinetics of CD86 elevation on APCs. Hydrolyzing ATP or blocking its P2X 7 receptor normalized APC CD86 expression and eliminated hypertension-induced T cell over-activation. Further, untreated human hypertensive patients have substantially elevated plasma ATP levels (2.21 ± 0.99 μM, n = 27) compared to treated hypertensive patients (0.94 ± 0.34 μM, n = 17) or normotensive controls (0.63 ± 0.38 μM, n =30). A linear trend was observed between ATP levels and BP among all subjects. These studies indicate ATP is critical in initiating hypertension-associated inflammation.

ATP drives lamina propria TH17 cell differentiation

ATP conditions intestinal epithelial cells to an inflammatory state that promotes components of DC maturation

T Follicular Helper Cells Promote a Beneficial Gut Ecosystem for Host Metabolic Homeostasis by Sensing Microbiota-Derived Extracellular ATP

Lack of ATP2B1 in CD4+ T Cells Causes Colitis

ATP released by intestinal bacteria limits the generation of protective IgA against enteropathogens

Abstract 130: ATP Release Drives the Immune Responses Associated with Hypertension

ATP-gated ionotropic P2X7 receptor controls follicular T helper cell numbers in Peyer's patches to promote host-microbiota mutualism

The ATP-hydrolyzing ectoenzyme E-NTPD8 attenuates colitis through modulation of P2X4 receptor-dependent metabolism in myeloid cells

Extracellular adenosine triphosphate skews the T helper cells balance and enhances neutrophils activation in mice with food allergy

Adenosine-5'-Triphosphate (Atp) Protects Mice Against Bacterial Infection By Activation Of The Nlrp3 Inflammasome

Adenosine Triphosphate Promotes Allergen-Induced Airway Inflammation and Th17 Cell Polarization in Neutrophilic Asthma

Resident TH2 cells orchestrate adipose tissue remodeling at a site adjacent to infection

Neutrophil extracellular traps and their histones promote Th17 cell differentiation directly via TLR2

Commensal A4 Bacteria Inhibit Intestinal Th2-Cell Responses Through Induction Of Dendritic Cell Tgf-Beta Production

Th2 cytokine-primed airway smooth muscle cells induce mast cell chemotaxis via secretion of ATP

The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation

T helper 17 (Th17) cell responses to the gut microbiota in human diseases

Glycolytic ATP fuels phosphoinositide 3-kinase signaling to support effector T helper 17 cell responses

A RORγt+ cell instructs gut microbiota-specific Treg cell differentiation

Extracellular ATP is an environmental cue in bacteria

ATP triggers a robust intracellular [Ca2+ ]-mediated signalling pathway in human synovial fibroblasts